Skip to content
Cancer Institute NSW sites
eviQ Education
Learning resources for cancer staff
opens in a new tab or window
Cancer Institute NSW
NSW cancer control agency
opens in a new tab or window
Patient Information
Practical advice about cancer
opens in a new tab or window
Canrefer
Find a cancer specialist
opens in a new tab or window
BreastScreen NSW
Detect breast cancer early
opens in a new tab or window
Cervical Screening NSW
Cervical Screening NSW
opens in a new tab or window
iCanQuit
Learn how to quit smoking
opens in a new tab or window
Log in
Register
Search
Search
Log in
Register
Search
Main menu Toggle menu collaspe
Search eviQ
Close
Search
Search
Home
Home
Cancer genetics
Adult
Genetic testing for heritable pathogenic variants
Genetic testing using cancer gene panels
Risk management
Paediatric
Genetic testing for heritable pathogenic variants
Genetic testing using cancer gene panels
Risk management
Referral guidelines
Consumer information
Resources
Haematology and BMT
Leukaemias
Acute lymphoblastic leukaemia
Acute myeloid leukaemia
Acute promyelocytic leukaemia
Chronic lymphocytic leukaemia
Chronic myeloid leukaemia
Hairy cell leukaemia
Myelodysplastic disorders
Lymphoma
Hodgkin lymphoma
Burkitt lymphoma
Mantle cell lymphoma
NK-cell and T-cell lymphoma
Other B-cell lymphoma
Primary CNS lymphoma
Waldenstrom macroglobulinaemia
Multiple myeloma
Blood and marrow transplant
Mobilisation
Allogeneic
Autologous
GVHD prophylaxis
Cellular therapies
Medical oncology
Breast
Neoadjuvant/Adjuvant
Metastatic
Colorectal
Adjuvant and neoadjuvant
Metastatic
Anal
Rectal
Gynaecological
Cervical
Endometrial
Gestational trophoblastic disease
Ovarian
Vulval
Head and neck
Definitive chemoradiation
Induction chemotherapy
Nasopharyngeal
Post operative chemoradiation
Recurrent or metastatic
Salivary gland
Thyroid
Neurological
Glioma
Respiratory
Mesothelioma
Non small cell lung cancer - Adjuvant/neoadjuvant
Non small cell lung cancer - Advanced/metastatic
Small cell lung cancer
Sarcoma
Soft tissue sarcoma
Bone sarcoma
Skin
Melanoma neoadjuvant/adjuvant
Melanoma metastatic
Non-melanoma
Upper gastrointestinal
Gastric and oesophageal adjuvant and neoadjuvant
Gastric and oesophageal metastatic
Gastrointestinal stromal cell tumours
Hepatic
Neuroendocrine
Pancreas and biliary
Urogenital
Adrenocortical
Bladder and Urothelial
Prostate
Renal
Testicular
Penile
Rare cancers
Colorectal
Gynaecological
Head and neck
Melanoma
Neurological
Respiratory
Sarcoma
Upper gastrointestinal
Urogenital
Tumour-agnostic
Tumour-agnostic
Radiation oncology
Breast
Colorectal
Gynaecological
Haematology
Head and neck
Neurological
Palliative
Respiratory
Upper gastrointestinal
Urogenital
Bladder
Prostate
Kidney and adrenal
Skin
Stereotactic
Clinical resources
eviQ calculators
Aboriginal health workers
ADDIKD guideline
Administration of anti-cancer drugs
Assessment tools
BMT & cellular therapies
Central venous access devices (CVADs)
Day of Treatment Assessment
Extravasation
Pumps
Health professional fact sheets
Oncological emergencies
Radiation oncology
Assessment tools
Cardiac implantable electronic devices
Contrast administration
Radiation-induced dermatitis
Side effect and toxicity management
Side effect and toxicity management
Cardiovascular
Gastrointestinal
General
Genitourinary
Gynaecological
Haematological
Hair, skin and nails
Immunological
Neurological and sensory
Oropharyngeal
Prophylaxis and treatment
Reproductive
Respiratory
Telephone triage toolkit
Patients and carers
Anticancer drug treatments
Radiation therapy treatments
Cancer genetics information sheets
Patient information sheets
At home
Cancer type specifics
Complementary and alternative medicines
Eating and drinking
Fertility, sex, pregnancy and breastfeeding
Treating cancer with medicines
How you have anticancer medicine treatment
Treating cancer with radiation therapy
Managing side effects
Vaccinations
Your family and friends
Patient information in other languages
عربى (Arabic)
简 (Simplified Chinese)
繁 (Traditional Chinese)
Français (French)
Ελληνικά (Greek)
Italiano (Italian)
한국어 (Korean)
Español (Spanish)
Tiếng Việt (Vietnamese)
Македонски (Macedonian)
ไทย (Thai)
Patient information videos
Cancer Institute NSW sites
eviQ Education
Learning resources for cancer staff
opens in a new tab or window
Cancer Institute NSW
NSW cancer control agency
opens in a new tab or window
Patient Information
Practical advice about cancer
opens in a new tab or window
Canrefer
Find a cancer specialist
opens in a new tab or window
BreastScreen NSW
Detect breast cancer early
opens in a new tab or window
Cervical Screening NSW
Cervical Screening NSW
opens in a new tab or window
iCanQuit
Learn how to quit smoking
opens in a new tab or window
Home
Patients and carers
Anticancer drug treatments
Lymphoma
Search
Patient information - Lymphoma - Bendamustine and rituximab
Patient information - Lymphoma - Brentuximab vedotin
Patient information - Lymphoma - DHAP (dexamethasone, cytarabine, cisplatin)
Patient information - Lymphoma - GDP (gemcitabine, dexamethasone, cisplatin)
Patient information - Lymphoma - Gemcitabine and vinorelbine
Patient information - Zanubrutinib
Hodgkin lymphoma
Patient information - Hodgkin lymphoma - ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) advanced stage
Patient information - Hodgkin lymphoma - ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) early stage
Patient information - Hodgkin lymphoma - BEACOPDac escalated dose (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, dacarbazine, prednisolone)
Patient information - Hodgkin lymphoma - BEACOPP escalated dose (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procabazine, prednisolone)
Patient information - Hodgkin lymphoma - Brentuximab vedotin
Patient information - Hodgkin lymphoma - BV-AVD (brentuximab vedotin, doxorubicin, vinblastine, dacarbazine)
Patient information - Hodgkin lymphoma - BV-ICE (brentuximab vedotin iFOSFamide cARBOplatin etoposide)
Patient information - Hodgkin lymphoma - ChlVPP (chlorambucil, vinblastine, procarbazine, prednisolone)
Patient information - Hodgkin lymphoma - DHAP (dexamethasone, cytarabine, cisplatin)
Patient information - Hodgkin lymphoma - GDP (gemcitabine, dexamethasone, cisplatin)
Patient information - Hodgkin lymphoma - Gemcitabine and vinorelbine
Patient information - Hodgkin lymphoma - ICE (fractionated ifosfamide, carboplatin, etoposide)
Patient information - Hodgkin lymphoma - ICE (infusional ifosfamide, carboplatin, etoposide)
Patient information - Hodgkin lymphoma - IGEV (iFOSFamide gemcitabine vinORELBine prednisolone)
Patient information - Hodgkin lymphoma - Pembrolizumab
Patient information - Hodgkin lymphoma - PVAG (prednisolone, vinblastine, doxorubicin, gemcitabine)
Burkitt lymphoma
Patient information - Burkitt lymphoma - DA-R-EPOCH (dose adjusted rituximab, etoposide, prednisolone, vincristine, cyclophosphamide, doxorubicin)
Mantle cell lymphoma
Patient information - Acalabrutinib
Patient information - Mantle cell lymphoma - Ibrutinib
Patient information - Mantle cell lymphoma - R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone)
Patient information - Mantle cell lymphoma - R-DHAP (rituximab, dexamethasone, cytarabine, cisplatin)
Patient information - Mantle cell lymphoma - Rituximab maintenance
Patient information - Mantle cell lymphoma - Rituximab, bendamustine and cytarabine
Patient information - Mantle cell lymphoma - Zanubrutinib
NK-cell and T-cell lymphoma
Patient information - Cutaneous T-Cell Lymphoma (CTCL) - Vorinostat
Patient information - Lymphoma - Lymphoma - GDP (gemcitabine dexamethasone, cisplatin,)
Patient information - Lymphoma - Lymphoma brentuximab vedotin
Patient information - Natural killer/T-Cell lymphoma - DDGP (dexamethasone, cisplatin, gemcitabine, pegaspargase)
Patient information - Natural killer/T-Cell lymphoma - Modified SMILE (dexamethasone, methotrexate, ifosfamide, pegaspargase, etoposide)
Patient information - Nelarabine
Patient information - Non-Hodgkin lymphoma (NHL) - CHOEP14 (cyclophosphamide, doxorubicin, vincristine, etoposide, prednisolone)
Patient information - Non-Hodgkin lymphoma (NHL) - CHOEP21 (cyclophosphamide, doxorubicin, vincristine, etoposide, prednisolone)
Patient information - Non-Hodgkin lymphoma (NHL) - CHOP14 (cyclophosphamide, doxorubicin, vincristine, prednisolone)
Patient information - Non-Hodgkin lymphoma (NHL) - CHOP21 (cyclophosphamide, doxorubicin, vincristine, prednisolone)
Patient information - Peripheral T-Cell lymphoma (PTCL) - BV-CHP (brentuximab vedotin, cyclophosphamide, doxorubicin and prednisolone)
Patient information - Peripheral T-Cell lymphoma (PTCL) - Pralatrexate
Patient information - Peripheral T-cell lymphoma romidepsin
Other B-cell lymphoma
Patient information - Diffuse large B-cell lymphoma - Glofitamab and obinutuzumab
Patient information - Hairy cell leukaemia - Cladribine
Patient information - Hairy cell leukaemia - Rituximab and cladribine
Patient information - Lymphoma - Pembrolizumab
Patient information - Non-Hodgkin lymphoma - O-CVP (obinuzutumab, cyclophosphamide, vincristine, prednisolone)
Patient information - Non-Hodgkin lymphoma (NHL) - Bendamustine and obinutuzumab
Patient information - Non-Hodgkin lymphoma (NHL) - Bendamustine and rituximab
Patient information - Non-Hodgkin lymphoma (NHL) - Bendamustine polatuzumab vedotin and rituximab
Patient information - Non-Hodgkin lymphoma (NHL) - Brentuximab vedotin
Patient information - Non-Hodgkin lymphoma (NHL) - Chlorambucil and rituximab
Patient information - Non-Hodgkin lymphoma (NHL) - DA-R-EPOCH (dose adjusted rituximab, etoposide, prednisolone, vincristine, cyclophosphamide, doxorubicin)
Patient information - Non-Hodgkin lymphoma (NHL) - DHAC (dexamethasone, cytarabine, carboplatin)
Patient information - Non-Hodgkin lymphoma (NHL) - DHAP (dexamethasone, cytarabine, cisplatin)
Patient information - Non-Hodgkin lymphoma (NHL) - ESHAP (etoposide, methylprednisolone, cytarabine, cisplatin)
Patient information - Non-Hodgkin lymphoma (NHL) - GDP (gemcitabine, dexamethasone, cisplatin)
Patient information - Non-Hodgkin lymphoma (NHL) - Gemcitabine and vinorelbine
Patient information - Non-Hodgkin lymphoma (NHL) - ICE (fractionated ifosfamide, carboplatin, etoposide)
Patient information - Non-Hodgkin lymphoma (NHL) - ICE (infusional ifosfamide, carboplatin, etoposide)
Patient information - Non-Hodgkin lymphoma (NHL) - Idelalisib
Patient information - Non-Hodgkin lymphoma (NHL) - Obinutuzumab maintenance
Patient information - Non-Hodgkin lymphoma (NHL) - O-CHOP21 (obinutuzumab, cyclophosphamide, doxorubicin, vincristine, prednisolone)
Patient information - Non-Hodgkin lymphoma (NHL) - Pola-R-CHP (polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, prednisolone)
Patient information - Non-Hodgkin lymphoma (NHL) - R-CHOEP14 (rituximab, cyclophosphamide, doxorubicin, vincristine, etoposide, prednisolone)
Patient information - Non-Hodgkin lymphoma (NHL) - R-CHOP14 (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone)
Patient information - Non-Hodgkin lymphoma (NHL) - R-CHOP21 (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone)
Patient information - Non-Hodgkin lymphoma (NHL) - R-CVP (rituximab, cyclophosphamide, vincristine, prednisolone)
Patient information - Non-Hodgkin lymphoma (NHL) - R-DHAOx (rituximab, dexamethasone, cytarabine, oxaliplatin)
Patient information - Non-Hodgkin lymphoma (NHL) - R-DHAP (rituximab, dexamethasone, cytarabine, cisplatin)
Patient information - Non-Hodgkin lymphoma (NHL) - R-GDP (rituximab, gemcitabine, dexamethasone, cisplatin)
Patient information - Non-Hodgkin lymphoma (NHL) - R-GemOx (rituximab, gemcitabine, oxaliplatin)
Patient information - Non-Hodgkin lymphoma (NHL) - RICE (rituximab, fractionated ifosfamide, carboplatin, etoposide)
Patient information - Non-Hodgkin lymphoma (NHL) - RICE (rituximab, infusional ifosfamide, carboplatin, etoposide)
Patient information - Non-Hodgkin lymphoma (NHL) - Rituximab
Patient information - Non-Hodgkin lymphoma (NHL) - Rituximab maintenance
Patient information - Non-Hodgkin lymphoma (NHL) - Rituximab maintenance subcutaneous
Patient information - Non-Hodgkin lymphoma (NHL) - R-MiniCHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone)
Patient information - Non-Hodgkin lymphoma (NHL) - SMARTE-R-CHOP14 (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone)
Patient information - Non-Hodgkin lymphoma (NHL) - Tafasitamab and lenalidomide
Primary CNS lymphoma
Patient information - Primary CNS lymphoma - High dose methotrexate
Patient information - Primary CNS lymphoma - MATRix (methotrexate, cytarabine, thiotepa, rituximab)
Patient information - Primary CNS lymphoma - Methotrexate and cytarabine
Waldenstrom macroglobulinaemia
Patient information - Waldenstrom macroglobulinaemia - DRC (dexamethasone, rituximab, cyclophosphamide)
Patient information - Waldenstrom macroglobulinaemia - Zanubrutinib
No results to display
Title
Content